5 patents currently held
6 more in force are now held by other companies
Held is read from USPTO's recorded assignments; a transfer never recorded there does not appear.
2 more records may belong here and await a decision; they are not counted.
The next term ends in Aug 2027. from the record
Of the 6 now held by other companies, 6 name J and K Ingredients LLC as their current owner. Each row says so.
Free plan: 3 watched companies. Pro: unlimited.
Alerts on its grants, lapses and transfers.
2
Ending by 2030
Aug 2027
Next term end
5
Patent families
When these terms end
Held patents by the year their term ends
notable patents
all others
Updated Nov 14, 2026 · includes USPTO assignment & status data published Nov 14, 2026 and grant & fee data published Nov 10, 2026 (weekly) · how we know
Notable: the highest-ranked patents in this portfolio by citations and family size.
Notable patents
Ranked by citations and family size, against patents of the same kind granted the same year. How we rank
Notable
Ends Aug 2027 · Medium confidence
Also notable
Ends Jan 2028 · High confidence
Also notable
Ends Nov 2033 · High confidence
Low Sodium Salt Composition
US 9,629,384
The most cited patent in this portfolio, cited by 68 later US patents, top 5% of utility patents granted in 2017 in our data. Protection runs to 2027.
Method for Producing a Low Sodium Salt Composition
US 7,989,016
The largest patent family in this portfolio, 5 related applications, renewed at 3 of 3 maintenance windows. Protection runs to 2028.
Compositions of Low Sodium Salt and Methods of Making and Using
US 9,011,963
Granted 2015 and renewed at every maintenance window due so far. Protection runs to 2033.
Formerly held, still cited
Notable
Ends Jun 2039 · High confidence
Cited by 3 later US patents, top 25% of utility patents granted in 2023 in our data. Protection runs to 2039. A terminal disclaimer caps this term to an earlier patent's.
now held by J&K Ingredients, LLC
Fee deadlines
Maintenance fees fall due 3.5, 7.5 and 11.5 years after grant. A missed fee ends a patent at the end of the six month grace period that follows, not on the due date.
- 1 fee due Aug 2, 2027The maintenance fee for Salt Substitute with Plant Tissue Carrier (US 9,247,762) comes due Aug 2, 2027. Unpaid by Feb 2, 2028, it lapses early.
Recent changes
- 4 terms have ended since Aug 16, 2026
What they patent
The 3 largest of its 5 families, grouped by real patent family and labeled by the earliest filing in each. No technology classification is inferred from titles.
| Low Sodium Salt Substitute with Potassium Chloride | 1 in force | to Jun 2038 |
| Method for Producing a Low Sodium Salt Composition | 1 in force | to Jan 2028 |
| Low Sodium Salt Composition | 1 in force | to Aug 2027 |
Patents held now
Soonest term end first.
Showing 1 to 5 of 5
| Patent | Title | Status | Expires | Confidence |
|---|---|---|---|---|
| US 9,629,384 | Low Sodium Salt Composition In force · Medium confidence | In force | Medium confidence | |
| US 7,989,016 | Method for Producing a Low Sodium Salt Composition In force · High confidence | In force | High confidence | |
| US 9,011,963 | Compositions of Low Sodium Salt and Methods of Making and Using In force · High confidence | In force | High confidence | |
| US 9,247,762 | Salt Substitute with Plant Tissue Carrier In force · High confidence | In force | High confidence | |
| US 11,051,539 | Low Sodium Salt Substitute with Potassium Chloride In force · High confidence | In force | High confidence |
Also on record, not counted in the 5: 6 patents in force now held by others · 5 patents ended · 5 applications abandoned. List them
Sources and methods
Compiled from USPTO application file histories, grants and recorded assignments, with the company's own names reviewed by hand. How this record was built
Portfolio grouped automatically from ownership conveyances to the names matched to this company, usually every name that begins with its own, so it counts patents an affiliate holds; each list row names the holder of record. Security interests are excluded and ambiguous records are not reviewed by hand.
Computed patent terms end on the dates shown. Related patents and pending applications may cover overlapping subject matter.